Literature DB >> 1792241

Interactions of colchicine with tubulin.

S B Hastie1.   

Abstract

Colchicine exerts its biological effects through binding to the soluble tubulin heterodimer, the major component of the microtubule. The colchicine-binding abilities of tubulins from a variety of sources are summarized, and the mechanism of colchicine binding to brain tubulin is explored in depth. The relationship between colchicinoid structure and tubulin binding activity provides insight into the structural features of colchicine responsible for high affinity binding to tubulin and is reviewed for analogs in the colchicine series. The thermodynamic and kinetic aspects of the association are described and evaluated in terms of the binding mechanism. Colchicine binding to tubulin results in unusual alterations in the low energy electronic spectra of colchicine. The spectroscopic features of colchicine bound to tubulin are discussed in terms of the nature of the colchicine-tubulin complex. Attempts to locate the high affinity colchicine binding site on tubulin are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792241     DOI: 10.1016/0163-7258(91)90067-v

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  46 in total

1.  Characterization of the colchicine binding site on avian tubulin isotype betaVI.

Authors:  Shubhada Sharma; Barbara Poliks; Colby Chiauzzi; Rudravajhala Ravindra; Adam R Blanden; Susan Bane
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

2.  In silico design of tubulin-targeted antimitotic peptides.

Authors:  Stefano Pieraccini; Giorgio Saladino; Graziella Cappelletti; Daniele Cartelli; Pierangelo Francescato; Giovanna Speranza; Paolo Manitto; Maurizio Sironi
Journal:  Nat Chem       Date:  2009-10-23       Impact factor: 24.427

3.  Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10.

Authors:  B M Riederer; V Pellier; B Antonsson; G Di Paolo; S A Stimpson; R Lütjens; S Catsicas; G Grenningloh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.

Authors:  Sangram S Kale; Ganesh S Jedhe; Sachin N Meshram; Manas K Santra; Ernest Hamel; Gangadhar J Sanjayan
Journal:  Bioorg Med Chem Lett       Date:  2015-03-14       Impact factor: 2.823

5.  Analysis of the strength of interfacial hydrogen bonds between tubulin dimers using quantum theory of atoms in molecules.

Authors:  Ahmed T Ayoub; Travis J A Craddock; Mariusz Klobukowski; Jack Tuszynski
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

6.  Screening Anti-Cancer Drugs against Tubulin using Catch-and-Release Electrospray Ionization Mass Spectrometry.

Authors:  Reza Rezaei Darestani; Philip Winter; Elena N Kitova; Jack A Tuszynski; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-04       Impact factor: 3.109

7.  Rapid and Reversible High-Affinity Binding of the Dinitroaniline Herbicide Oryzalin to Tubulin from Zea mays L.

Authors:  J. D. Hugdahl; L. C. Morejohn
Journal:  Plant Physiol       Date:  1993-07       Impact factor: 8.340

Review 8.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.

Authors:  Yong Jin Kim; Eun Ae Kim; Mi Lyang Chung; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

10.  Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

Authors:  M A Robin; M Maratrat; M Le Roy; F P Le Breton; E Bonierbale; P Dansette; F Ballet; D Mansuy; D Pessayre
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.